Home › Head and Neck Cancer › Alabama › Birmingham
Head and Neck Cancer clinical trials in Birmingham, AL
5 studies for Head and Neck Cancer are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
RecruitingPhase 2/3
- Site # 0137, Birmingham
DESTINY-PANTUMOUR04
RecruitingObservational study
- Research Site, Birmingham
Phase II Panitumumab-IRDye800 in Head & Neck Cancer
RecruitingPhase 2
- University of Alabama at Birmingham, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Birmingham
A Motion Exergaming Approach for Symptom Management: HNC
Recruiting
- University of Alabama at Birmingham, Birmingham
About Head and Neck Cancer
Head and neck cancer includes cancers of the mouth, nose, sinuses, salivary glands, throat, and lymph nodes. Read the different symptoms of each type.
More about Head and Neck Cancer on MedlinePlus
Head and Neck Cancer trials in other cities
- Houston, TX30 studies
- Boston, MA22 studies
- Nashville, TN21 studies
- New York City, NY21 studies
- St. Louis, MO15 studies
- Dallas, TX12 studies
- Pittsburgh, PA11 studies
- San Antonio, TX10 studies
- Los Angeles, CA10 studies
- Baltimore, MD10 studies
- Washington, DC10 studies
- Durham, NC10 studies
Other studies in Birmingham
- Cancer (all types)31 studies
- Breast Cancer24 studies
- Ovarian Cancer23 studies
- Obesity23 studies
- Non-Small Cell Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Multiple Myeloma18 studies
- COPD17 studies
- Cardiovascular Disease17 studies
- Type 2 Diabetes16 studies
- Endometrial Cancer16 studies
- Overweight16 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.